Complete defect in vWF-cleaving protease activity associated with increased shear-induced platelet aggregation in thrombotic microangiopathy

被引:16
作者
Ajzenberg, N [1 ]
Denis, CV [1 ]
Veyradier, A [1 ]
Girma, JP [1 ]
Meyer, D [1 ]
Baruch, D [1 ]
机构
[1] Hop Bicetre, INSERM, U143, Paris, France
关键词
platelet; non Willebrand factor; thrombotic thrombocytopenic purpura; metalloprotease;
D O I
10.1055/s-0037-1613088
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Von Willebrand factor (vWF) cleaning metalloprotease activity represents an important factor in understanding the pathophysiology of thrombotic microangiopathies (TMA). Thrombotic events. leading to dramatic complications. occur preferentially in the microvasculature. Our aim was to determine the ability of TMA plasma with a complete deficiency of protease activity to promote shear-induced platelet aggregation (SIPA) at high shear rates using a coaxial cylinder shearing device. We have demonstrated the ability of four out of seven TMA plasma to aggregate normal washed platelets at 4.000 s(-1). In these four TMA plasma. significant SIPA was obtained. whereas control plasma did not induce more SIPA than buffer. The % of unusually large (UL) multimers in TMA plasma varied from 1 to 18%. Surprisingly, the extent of SIPA in TMA plasma appeared independent of the percentage of UL multimers. Interestingly, anti-GPIb antibody 6D1 could block completely this pathological aggregation. opening new therapeutic possibilities. In contrast. none of eight other TMA patients' plasma with a normal protease activity, exhibited any increase of SIPA compared with control plasma. These results strongly suggest that the deficiency of vWF-cleaving protease appears to be necessary, but not sufficient for elevated SIPA. In contrast. the % of UL is not associated with increased SIPA.
引用
收藏
页码:808 / 811
页数:4
相关论文
共 25 条
  • [1] Ajzenberg N, 2000, BLOOD, V95, P3796
  • [2] Thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome
    Baker, KR
    Moake, JL
    [J]. CURRENT OPINION IN PEDIATRICS, 2000, 12 (01) : 23 - 28
  • [3] Antithrombotic effect of platelet glycoprotein Ib-blocking monoclonal antibody Fab fragments in nonhuman primates
    Cauwenberghs, N
    Meiring, M
    Vauterin, S
    van Wyk, V
    Lamprecht, S
    Roodt, JP
    Novák, L
    Harsfalvi, J
    Deckmyn, H
    Kotzé, HF
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (05) : 1347 - 1353
  • [4] COLLER BS, 1983, BLOOD, V61, P99
  • [5] Depraetere H, 1998, BLOOD, V91, P3792
  • [6] Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family
    Fujikawa, K
    Suzuki, H
    McMullen, B
    Chung, D
    [J]. BLOOD, 2001, 98 (06) : 1662 - 1666
  • [7] Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura
    Furlan, M
    Robles, R
    Solenthaler, M
    Wassmer, M
    Sandoz, P
    Lammle, B
    [J]. BLOOD, 1997, 89 (09) : 3097 - 3103
  • [8] Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome
    Furlan, M
    Robles, R
    Galbusera, M
    Remuzzi, G
    Kyrle, PA
    Brenner, B
    Krause, M
    Scharrer, I
    Aumann, V
    Mittler, U
    Solenthaler, M
    Lämmle, B
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (22) : 1578 - 1584
  • [9] A novel interpretation of the role of von Willebrand factor in thrombotic microangiopathies based on platelet adhesion studies at high shear rate flow
    Galbusera, M
    Remuzzi, A
    Benigni, A
    Rossi, C
    Remuzzi, G
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (04) : 695 - 702
  • [10] How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome
    George, JN
    [J]. BLOOD, 2000, 96 (04) : 1223 - 1229